Saxagliptin, sold under the brand name Onglyza, is an oral hypoglycemic of the dipeptidyl peptidase-4 inhibitor class. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on thmore...
Offered tablet is precisely processed using the finest quality chemical compounds and ultra-modern technology at vendors’ end in accordance with industry quality norms. In addition to this, provided tablet is inspected under the guidance of our quality examiners on differenmore...
product details: dose/strength (ex. 1 mg or 1ml)5mg packaging size28 packaging typebox usagecommercial usageclinical, hospital, personal onglyza (saxagliptin) 5mg onglyza (saxagliptin) is an oral dipeptidyl peptidase 4 (dpp-4) inhibitor used for the treatment of type 2 diabetesmore...